178 0

Improving Participation in Clinical Trials of Novel Therapies: Going Back to Basics

Title
Improving Participation in Clinical Trials of Novel Therapies: Going Back to Basics
Author
배상철
Keywords
Systemic lupus erythematosus; Randomized clinical trials; Enrollment; Retention
Issue Date
2014-08
Publisher
W B SAUNDERS CO-ELSEVIER INC
Citation
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2014, 40(3), pp. 553-559
Abstract
Clinical trials in many diseases are experiencing'more difficulties in achieving sufficient or timely enrollment of participants; anecdotal reports from trials of novel therapies for systemic lupus erythematosus (SLE) seem to be facing the same challenges. General factors associated with this trend include the growth of the contract research industry, increasing oversight, and high-profile accounts of scientific misconduct and fraud in research. Complicated protocols that increase participant burden, overly restrictive entry criteria, the fear of an SLE flare may also affect enrollment in SLE trials.
URI
https://www.sciencedirect.com/science/article/pii/S0889857X14000441?via%3Dihubhttp://hdl.handle.net/20.500.11754/47612
ISSN
0889-857X; 1558-3163
DOI
10.1016/j.rdc.2014.05.002
Appears in Collections:
COLLEGE OF MEDICINE[S](의과대학) > MEDICINE(의학과) > Articles
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE